Roche’s Third Quarter Results 2022
Roche has published its Third Quarter Sales results for 2022 prior to the opening of the Swiss Stock Exchange on Tuesday, 18th October 2022. Please register to access the replay of the webinar.
| Agenda | |
|---|---|
| Overview | Bruno Eschli, Head of Investor Relations |
| Pharmaceuticals Division | Bill Anderson, CEO Roche Pharmaceuticals |
| Diagnostics Division | Thomas Schinecker, CEO Roche Diagnostics |
| Financial Results | Alan Hippe, Chief Financial and IT Officer |
| Questions and answers |
Webinar Replay
Investors